Report Categories Report Categories

Report Categories

industry Category

All

Total: 6 records, 1 pages

Global Total Artificial Heart Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Medical Devices & Consumables

new_biaoQian Total Artificial Heart

The global Total Artificial Heart market size is expected to reach $ 150.3 million by 2030, rising at a market growth of 20.8% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Total Artificial Heart Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Devices & Consumables

new_biaoQian Total Artificial Heart

According to our (Global Info Research) latest study, the global Total Artificial Heart market size was valued at USD 40 million in 2023 and is forecast to a readjusted size of USD 150.3 million by 2030 with a CAGR of 20.8% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Temporary Total Artificial Heart (TAH) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 14 Jan 2024

date Medical Devices & Consumables

new_biaoQian Temporary Total Artificial Heart (TAH)

According to our (Global Info Research) latest study, the global Temporary Total Artificial Heart (TAH) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Total Artificial Heart Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Devices & Consumables

new_biaoQian Total Artificial Heart

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

USD3480.00

Add To Cart

Add To Cart

Global Temporary Total Artificial Heart (TAH) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Sep 2023

date Medical Devices & Consumables

new_biaoQian Temporary Total Artificial Heart (TAH)

According to our (Global Info Research) latest study, the global Temporary Total Artificial Heart (TAH) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Temporary Total Artificial Heart (TAH) Supply, Demand and Key Producers, 2023-2029

date 06 Sep 2023

date Medical Devices & Consumables

new_biaoQian Temporary Total Artificial Heart (TAH)

The global Temporary Total Artificial Heart (TAH) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

industry 10 Feb 2024

industry Medical Devices & Consumables

new_biaoQian Total Artificial Heart

The global Total Artificial Heart market size is expected to reach $ 150.3 million by 2030, rising at a market growth of 20.8% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Medical Devices & Consumables

new_biaoQian Total Artificial Heart

According to our (Global Info Research) latest study, the global Total Artificial Heart market size was valued at USD 40 million in 2023 and is forecast to a readjusted size of USD 150.3 million by 2030 with a CAGR of 20.8% during review period.

USD3480.00

addToCart

Add To Cart

industry 14 Jan 2024

industry Medical Devices & Consumables

new_biaoQian Temporary Total Artificial Heart (TAH)

According to our (Global Info Research) latest study, the global Temporary Total Artificial Heart (TAH) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Medical Devices & Consumables

new_biaoQian Total Artificial Heart

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

USD3480.00

addToCart

Add To Cart

industry 06 Sep 2023

industry Medical Devices & Consumables

new_biaoQian Temporary Total Artificial Heart (TAH)

According to our (Global Info Research) latest study, the global Temporary Total Artificial Heart (TAH) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 06 Sep 2023

industry Medical Devices & Consumables

new_biaoQian Temporary Total Artificial Heart (TAH)

The global Temporary Total Artificial Heart (TAH) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart